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Abstract
Purpose: Multi-drug-resistant tuberculosis (MDR-TB) is simultaneously resistant to isoniazid and rifampin. Of course, 
this germ may also be resistant to other anti-tuberculosis drugs. Patients with extensively drug-resistant tuberculosis 
(XDR-TB) are also resistant to all types of fluoroquinolone and at least one of the three injectable medications: amik-
acin, clarithromycin, or kanamycin, in addition to isoniazid and rifampin. Therefore, the main objective of the current 
study was to evaluate and compare the computed tomography (CT) scan findings of MDR-TB and XDR-TB patients.
Material and methods: In this comparative descriptive cross-sectional study 45 consecutive TB patients who referred to 
Masih Daneshvari Hospital, Tehran, Iran from 2013 to 2019 were enrolled. TB was diagnosed based on sputum smear 
and sensitive molecular and microbial tests. Patients were divided into two groups (MDR-TB and XDR-TB) based 
on two types of drug resistance. CT scan findings were compared for cavitary, parenchymal, and non-parenchymal 
disorders. The early diagnostic values of these factors were also calculated.
Results: Findings related to cavitary lesions including the pattern, number, size of the largest cavity, maximum thick-
ness of the cavity, lung involvement, number of lobes involved, and the air-fluid levels in the two patient groups were 
similar (p > 0.05). Parenchymal findings of the lung also included fewer and more nodules of 10 mm in the MDR-TB 
and XDR-TB groups, respectively. Tree-in-bud, ground-glass-opacity, bronchiectasis, cicatricial emphysema, and 
lobar atelectasis were similar in the two patient groups (p > 0.05). Findings outside the parenchymal lung, including 
mediastinal lymphadenopathy and pericardial effusion, showed no statistically significant difference between the 
MDR-TB and XDR-TB groups (p > 0.05). Parenchymal calcification was more common in the XDR group than in 
the MDR group (64.7% and 28.6%, respectively) with a significant difference (p = 0.01).
Conclusions: CT scan findings in patients with XDR-TB are similar to those of patients with MDR-TB for cavitary, 
parenchymal, and non-parenchymal lung characteristics. However, patients with XDR-TB tend to have more pa-
renchymal calcification and left-sided plural effusion. CT characteristics overlap between XDR-TB and those with 
MDR-TB. It can be concluded that CT scan features are not sensitive to the diagnosis.
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Introduction
Tuberculosis (TB) is an ancient disease occurring world-
wide with numerous early and late complications [1,2]. 
According to the World Health Organization (WHO) 
definition, multi-drug-resistant tuberculosis (MDR-TB) 
is resistant to both isoniazid and rifampin [3]. Of course, 
this germ may also be resistant to other anti-tuberculosis 
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drugs [3]. Lack of compliance by patients and self-discon-
tinuation are the main causes for drug resistance as well as 
single therapy and background diseases [3].
Patients with extensively drug-resistant tuberculosis 
(XDR-TB) are resistant to all types of fluoroquinolone and 
at least one of the three injectable medications (amikacin, 
clarithromycin, or kanamycin) in addition to isoniazid 
and rifampin [4]. In such cases, two years of continuous 
therapy is mandatory with direct observation by a phy-
sician [4]. In total, 3.2% of tuberculosis cases worldwide 
are drug resistant [4]. Usually MDR patients are younger 
and have multiple treatment sessions and cavitary involve-
ment [5]. Despite multiple studies comparing the clinical 
findings of MDR and XDR cases [6-8], few studies have 
compared imaging findings and TB characteristics [7,9-
16]. Therefore, the main objective of the current study was 
to evaluate and compare the CT scan findings of MDR-TB 
and XDR-TB patients.
Figure 1. 66 year-old male with extensively drug-resistant tuberculosis. 
Axial computed tomography scan of the lung showing cavitary consolida-
tion with airbronchogram in left lower lobe
Figure 2. Mediastinal window computed tomography scan of the same 
patient as in Figure 1 showing left sided pleural effusion
Figure 3. 51 year-old male with multi-drug-resistant tuberculosis. Axial 
computed tomography scan of the lung showing consolidation in right 
middle lobe with extensive nodular infilteration
Figure 4. The same patient as in Figure 3. Lung window computed tomog-
raphy scan showing a macronodule (black arrow) measuring 12 mm in right 
upper lobe. Note also micronodular infilteration of the same side
Material and methods
In this comparative descriptive cross-sectional study, 
a total of 45 consecutive TB patients who referred to 
Masih Daneshvari Hospital, Tehran, Iran between 2013 
and 2019 were enrolled. TB was diagnosed according to 
the WHO criteria by sputum smear and sensitive mo-
lecular and microbial tests. Additional inclusion criteria 
were age over 18 years, lacking chronic respiratory dis-
ease affecting the lung computed tomography (CT) scan 
findings, and the presence of CT scan results among ex-
isting medical documents. Patients were divided into two 
groups: MDR-TB and XDR-TB, based on two types of 
drug resistance.
There were 17 eligible cases with XDR-TB and 28 ap-
propriate patients with MDR-TB among 136 MDR cases 
and 34 patients with XDR. CT scans findings were com-
pared for cavitary, parenchymal, and non-parenchymal 
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disorders. The early diagnostic values of these factors were 
also calculated (Figures 1–6).
Data analysis was done by SPSS version 25.0 software. 
The categorical variables were shown as frequencies and 
percentages. The numerical variables were demonstrated 
as mean and standard deviation. The c2, Kolmogorov- 
Smirnov, independent sample t-test, and Mann-Whitney 
U test were utilised. A p-value of less than 0.05 was con-
sidered statistically significant.
Results
The mean patient age was 43.1 ± 15.2 years (44.3 ± 15.5 
and 41.4 ± 15.2 in MDR and XDR cases, respectively; 
p > 0.05). Among the 45 subjects, 26 were men (17 MDR 
and 9 XDR) and 19 were women (11 MDR and 8 XDR); 
the difference was not significant (p > 0.05). Among the 
MDR and XDR cases, 21.4% and 8.9% were smokers, re-
spectively (p > 0.05). Previous first-line anti-TB therapy 
was positive in 57.8% and 37.8% of cases in the MDR 
and XDR groups, respectively (p > 0.05). The mean time 
intervals between CT scan and positive microbiology 
results were 26.2 ± 16 and 35.5 ± 14.4 days, respective-
ly, which showed no significant difference (p > 0.05). 
Diabetes and HIV were seen in seven and six cases, re-
spectively; this difference was not statistically significant 
(p > 0.05).
As shown in Table 1, the findings related to cavitary 
lesions including the pattern, number, size of the largest, 
maximum thickness of the cavity, lung involvement, num-
ber of involved lobes, and the air-fluid level in the two 
patient groups were similar (p > 0.05). In cavitary lesions, 
unilateral cases were more common in both MDR and 
XDR findings.
Table 1. Cavitary lesions across the groups
Variable MDR-TB XDR-TB p value
Cavitary 24 (85.7%) 13 (76.5%) 0.43
Pattern
In nodule and mass 16 (57.1%) 12 (70.6%) 0.36
In consolidation 12 (42.9%) 6 (35.3%) 0.61
In nodule and mass plus consolidation 4 (4.13%) 5 (29.4%) 0.21
Total number 1.5 ± 1 2 ± 2 0.39
Size of largest cavitary lesion (mm) 29 ± 25 45 ± 15 0.44
Largest thickness (mm) 5.5 ± 2 6 ± 2 0.44
Laterality
Unilateral 29 ± 25 9 (62.9%) 0.12
Bilateral 5.5 ± 2 4 (23.5%) 0.25
Number of lobes 1.3 ± 0.98 1.82 ± 1.70 0.20
Air-fluid level 7 (25.0%) 5 (29.4%) 0.74
Figure 6. 21 year-old female with extensively drug-resistant tuberculosis. 
Lung window computed tomography scan showing a cavitary lesion with 
air-fluid level (black arrow) associated with bronchiectasis in right upper 
lobe. Note also the fibrocavitary lesion involving left upper lobe 
Figure 5. 47 year-old male with extensively drug-resistant tuberculosis. 
Axial computed tomography scan of the lung showing bronchiectasis (white 
arrow) with cavity formation (black arrow) in right lower lobe
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As shown in Table 2, the parenchymal findings of the 
lung also included fewer and more nodules of 10 mm in 
the MDR and XDR groups, respectively. Tree-in-bud, 
ground-glass-opacity (GGO), bronchiectasis, cicatricial 
emphysema, and lobar atelectasis were similar in the two 
patient groups (p > 0.05). Parenchymal calcification was 
more common in the XDR group (64.7% vs. 28.6%), with 
a significant difference (p = 0.01). Micronodules, TIB, 
GGO, and bronchiectasis were more common findings in 
the XDR group, and micronodules, TIB, and bronchiectasis 
were more common findings in the MDR group.
As shown in Table 3, the findings outside of the pa-
renchymal lung, including mediastinal lymphadenopathy 
and pericardial effusion, showed no statistically significant 
difference between the MDR-TB and XDR-TB groups 
(p > 0.05). However, pleural effusion and mediastinal lym-
phadenopathy were most common findings in both the 
XDR and the MDR group.
Table 3. Extra-parenchymal lesions across the groups
Variable MDR-TB XDR-TB p value
Mediastinal lymphadenopathy 17 (60.7%) 10 (58.8%) 0.90
Pericardial effusion 2 (7.1%) 3 (17.6%) 0.27
Hilar lymphadenopathy 12 (43%) 10 (58.8%) 0.29
Hilar lymphadenopathy laterality
Unilateral 9 (32.1%) 9 (52.9%) 0.16
Bilateral 3 (10.7%) 1 (5.9%) 0.58
Not seen 16 (57.1%) 7 (41.2%) 0.29
Calcified lymphadenopathy 3 (10.7%) 5 (29.4%) 0.11
Pleural effusion 20 (71.7%) 16 (94.1%) 0.06
Pleural effusion laterality
Unilateral 15 (53.6%) 14 (82.4%) 0.051
Bilateral 5 (17.9%) 2 (11.8%) 0.58
No effusion 8 (28.6%) 1 (5.9%) 0.06
Loculated pleural effusion 3 (10.7%) 3 (10.7%) 0.58
Table 2. Parenchymal lesions across the groups
Variable MDR-TB XDR-TB p value
Micronodule < 10 mm*** 28 (100%) 17 (100%) 1.000
Number of lobes with micronodules* 3.96 ± 1.64 3.47 ± 1.74 0.35
Macronodule < 10 mm*** 15 (53.6%) 8 (47.1%) 0.67
Number of lobes with macronodules* 1 (0-2) 0 (0-1) 0.58
TIB*** 23 (82.1%) 15 (88.2) 0.58
Number of lobes with TIB* 2.71 ± 1.95 2 (1-2) 0.83
Ground glass opacity and consolidation*** 18 (64.3%) 15 (88.2%) 0.07
Number of lobes with ground glass opacity and consolidation** 1 (0-2) 2 (1-2) 0.10
Bronchiectasis*** 23 (82.1%) 15 (88.2%) 0.58
Number of lobes with bronchiectasis** 1 (0-2) 2 (1-3) 0.17
Cicatricial emphysema*** 4 (14.3%) 2 (11.8%) 0.80
Number of lobes with cicatricial emphysema** – – 0.85
Parenchymal calcification*** 8 (28.6%) 11 (64.7%) 0.01
Number of lobes with parenchymal calcification* 0.5 ± 0.18 0.76 ± 0.16 0.32
Lobar atelectasis*** 4 (14.3%) 3 (17.6%) 0.76
Number of lobes with lobar atelectasis** – – 0.70
*Mean ± SD tested by independent sample t-test
**Median and IQR tested by Mann-Whitney U test
***c2 test
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Discussion
Proper prescription of second-line anti-tuberculosis drugs 
must be ensured to thoroughly treat existing MDR-TB, re-
duce further transmission, and prevent the emergence of 
XDR-TB [17]. Interestingly, CT scanning may be used to 
monitor therapeutic responses after initial treatments for 
TB cases [18]. In the current study, the CT scan findings 
of MDR and XDR tuberculosis patients were compared. 
Only one significant difference that was related to paren-
chymal calcification with a significantly higher rate among 
XDR cases was found. Other common but non-significant 
findings in the XDR cases included greater cavity thick-
ness, bilateral cavities, number of lobes, GGO, pleural 
effusion, calcified lymphadenopathy, and consolidation. 
Overall, this study demonstrated that imaging findings 
are not useful in distinguishing between MDR and XDR 
tuberculosis.
Contrary to the current results, Cha et al. [10] noted 
a significant age difference between MDR and XDR groups. 
A lack of matching with the group-to-group method may 
explain the differing results. Some differences may relate to 
the age at which anti-TB treatment was initiated. Bacilli are 
currently transmitted to younger patients. Other factors in-
clude decreased immune response and sedentary lifestyle. 
Lee et al. [11] reported that cavities are more common in 
patients with XDR with further lobe involvement than in 
MDR patients. Wang et al. [9] reported that multiple cavi-
ties with thick-walled status are the most promising imaging 
sign for diagnosing MDR-TB. This issue was found to be 
true for both MDR and XDR patients in the current study.
Yeom et al. [14] reported extensive lung involvement 
in XDR and MDR patients compared with non-resistant 
cases. This result may be explained by the transposition of 
microorganism-containing fluid to the bronchial tree and 
further parenchymal involvement. In the current study, 
the type of cavitary lesion did not differ between XDR and 
MDR cases. Cha et al. [10] reported that multiplex cavities 
are more common in both MDR and XDR cases than in 
treatment-responsive cases. Fishman et al. [15] showed 
no difference in cavitary pattern between MDR and XDR 
cases. Other studies have assessed the level of cavitary 
involvement in AIDS patients [10,12,13]. Cha et al. [10] 
reported lower cavitation in immunosuppressed patients 
with a positive HIV status compared with HIV-negative 
patients with greater immunity. Therefore, as seen in the 
current study, cavitary lesions are the main pulmonary 
finding for MDR or XDR without AIDS.
In the current study, the parenchymal findings were 
similar across the XDR and MDR groups, except for pa-
renchymal calcification, which had a higher rate in XDR 
cases than in MDR patients. Furthermore, GGO and con-
solidation showed a borderline significance of 0.06. Ad-
ditional studies with larger sample sizes would demon-
strate definitively the relationship status. Cha et al. [10] 
showed that bronchial obstruction and large nodules are 
more common in MDR and XDR cases versus non-re-
sistant cases. Hence, the use of CT scanning to identify 
parenchymal lesions is recommended. The micronodules 
were also common in the current study, being found in all 
patients with either MDR or XDR. Yeom et al. [14] also 
showed a greater rate of parenchymal findings in patients 
compared with non-resistant cases.
Similarly, Lee et al. [11] showed that micronodules and 
bronchiectasis are more common in XDR than in MDR cas-
es. This issue would help to disseminate caseous necrosis 
and granulomatosis inflammation. This finding also showed 
the higher invasion rate of XDR compared with MDR cas-
es. When tree-in-bud and consolidation are accompanied 
by such findings, the presence of antimicrobial resistance is 
suggested, and further microbiological assessments would 
be beneficial. However, as shown in the current study, there 
are no distinguishing CT scan differences between MDR 
and XDR cases. Some studies have compared MDR and 
XDR cases with non-resistant cases [9,13]. Further cases of 
macronodules and bronchial obstruction were reported in 
MDR and XDR patients than in non-resistant patients. This 
higher rate of parenchymal involvement was also reported 
by Yeom et al. [14]. These findings indicate that the psy-
chopathological mechanism and course of development for 
MDR and XDR are the same [10].
The current study had some limitations: 1) existing 
medical data were used, which led to a small sample size 
from among those with CT scan results; 2) selection bias 
may be present because CT scans are usually ordered 
for patients with more severe symptoms with features of 
greater invasiveness; 3) the use of existing data led to de-
creased control on the imaging protocols, 4) the smaller 
sample size in the XDR group compared with the MDR 
group led to decreased potency of the presented analyses; 
and 5) previous studies [19,20] compared drug-resistant 
with drug-susceptible cases, whereas the current study 
could not include a control group among drug-sensitive 
cases. Enrolment of a control group would help emphasise 
the actual role of CT scanning in the treatment monitor-
ing of TB patients.
Conclusions
Overall, it may be concluded that CT scan findings in pa-
tients with XDR-TB are similar to those in patients with 
MDR-TB when considering cavitary, parenchymal, and 
non-parenchymal lung characteristics. However, XDR-TB 
patients tend to have more parenchymal calcification and 
left-sided plural effusion. CT characteristics overlap between 
patients with TB (XDR-TB) and those with MDR-TB (MDR-
TB). It can be concluded that CT scan features are not suf-
ficiently accurate to use in diagnosing grade of resistance.
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